Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiang Qu

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2020
Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III TrialJunjie Li, Keda Yu, Da Pang, et al.
Nature Communications|July 22, 2025
Quantitative evaluation of methods to analyze motion changes in single-particle experimentsGorka Muñoz-Gil, Harshith Bachimanchi, Jesús Pineda, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 31, 2024
Haplotype-Resolved Genotyping and Association Analysis of 1,020 β-Thalassemia Patients by Targeted Long-Read SequencingYuhua Ye, Chao Niu, Aiping Mao, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|April 26, 2026
Genetic dissection of clinical heterogeneity in Hemoglobin H patients by targeted long-read sequencingYuhua Ye, Chao Niu, Aiping Mao, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2020
Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III TrialJunjie Li, Keda Yu, Da Pang, et al.
Nature Communications|July 22, 2025
Quantitative evaluation of methods to analyze motion changes in single-particle experimentsGorka Muñoz-Gil, Harshith Bachimanchi, Jesús Pineda, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 31, 2024
Haplotype-Resolved Genotyping and Association Analysis of 1,020 β-Thalassemia Patients by Targeted Long-Read SequencingYuhua Ye, Chao Niu, Aiping Mao, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|April 26, 2026
Genetic dissection of clinical heterogeneity in Hemoglobin H patients by targeted long-read sequencingYuhua Ye, Chao Niu, Aiping Mao, et al.
Pageof 11